ExoCan is an exosome based oncology company developing innovative cancer diagnosis and therapeutics technologies.
Basic Information
ExoCan aims to translate the clinical potential of these tiny vesicles (exosomes) for better management of cancers by employing cross-disciplinary approaches at the forefront of exosomes research. Now, a complete molecular snapshot of a cancer is possible just by taking biofluid samples-urine, saliva, blood/serum and analysing their exosome contents for providing clinically relevant information non-invasively in cancer patients. ExoCan offers high throughput exosome assay systems which can be used for various purposes. Their product named ExoEnrich™ is an instant exosome isolation kit that allows high efficiency capture and purification of bio macromolecules containing exosomes from various bio fluids e.g cell culture media, urine, saliva, serum. ExoEnrich™ isolated exosomes are compatible for downstream analysis of proteins (western blotting), DNA, RNA (PCR), and other cargo molecules captured inside exosomes e.g. lipids, metabolites etc.
Legal Name
:
ExoCan Healthcare Technologies Private Limited
Headquarters
:
Pune, Maharashtra, India
Founding Date
:
2015
No. of Employees
:
<10
Core Team
:
1.
Aman Sharma
Founder & CSO
Funding
Investors
:
1.
Venture Center
HealthTech / MedTech / Healthcare
BioTech/BioPharmaceutical
HealthTech / MedTech / Healthcare
BioTech/BioPharmaceutical
Recently Added Startups
Recently Added Startups
HealthTech / MedTech / Healthcare
BioTech/BioPharmaceutical